Company Quick10K Filing
Helen of Troy
10-K 2021-02-28 Filed 2021-04-29
10-Q 2020-11-30 Filed 2021-01-08
10-Q 2020-08-31 Filed 2020-10-09
10-Q 2020-05-31 Filed 2020-07-10
10-K 2020-02-29 Filed 2020-04-29
10-Q 2019-11-30 Filed 2020-01-09
10-Q 2019-08-31 Filed 2019-10-10
10-Q 2019-05-31 Filed 2019-07-10
10-K 2019-02-28 Filed 2019-04-29
10-Q 2018-11-30 Filed 2019-01-09
10-Q 2018-08-31 Filed 2018-10-10
10-Q 2018-05-31 Filed 2018-07-10
10-K 2018-02-28 Filed 2018-04-30
10-Q 2017-11-30 Filed 2018-01-09
10-Q 2017-08-31 Filed 2017-10-10
10-Q 2017-05-31 Filed 2017-07-10
10-K 2017-02-28 Filed 2017-05-01
10-Q 2016-11-30 Filed 2017-01-09
10-Q 2016-08-31 Filed 2016-10-11
10-Q 2016-05-31 Filed 2016-07-11
10-K 2016-02-29 Filed 2016-04-29
10-Q 2015-11-30 Filed 2016-01-11
10-Q 2015-08-31 Filed 2015-10-13
10-Q 2015-05-31 Filed 2015-07-10
10-K 2015-02-28 Filed 2015-04-29
10-Q 2014-11-30 Filed 2015-01-09
10-Q 2014-08-31 Filed 2014-10-10
10-Q 2014-05-31 Filed 2014-07-10
10-K 2014-02-28 Filed 2014-04-29
10-Q 2013-11-30 Filed 2014-01-09
10-Q 2013-08-31 Filed 2013-10-10
10-K 2013-02-28 Filed 2013-04-29
10-Q 2012-11-30 Filed 2013-01-09
10-Q 2012-08-31 Filed 2012-10-10
10-Q 2012-05-31 Filed 2012-07-10
10-K 2012-02-29 Filed 2012-04-30
10-Q 2011-11-30 Filed 2012-01-06
10-Q 2011-08-31 Filed 2011-10-07
10-Q 2011-05-31 Filed 2011-07-11
10-K 2011-02-28 Filed 2011-05-16
10-Q 2010-11-30 Filed 2011-01-10
10-Q 2010-08-31 Filed 2010-10-06
10-Q 2010-05-31 Filed 2010-07-09
10-K 2010-02-28 Filed 2010-05-13
10-Q 2009-11-30 Filed 2010-01-11
8-K 2020-10-08
8-K 2020-10-06
8-K 2020-08-26
8-K 2020-07-09
8-K 2020-05-14
8-K 2020-05-04
8-K 2020-04-28
8-K 2020-03-30
8-K 2020-03-17
8-K 2020-01-28
8-K 2020-01-23
8-K 2020-01-08
8-K 2019-12-19
8-K 2019-10-08
8-K 2019-08-23
8-K 2019-07-09
8-K 2019-06-21
8-K 2019-05-21
8-K 2019-04-26
8-K 2019-01-08
8-K 2018-11-07
8-K 2018-10-09
8-K 2018-08-22
8-K 2018-07-09
8-K 2018-04-26
8-K 2018-03-01
8-K 2018-01-24
8-K 2018-01-08

Helen of Troy Financials

HELE Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
024 Pharma (EEIG)
11 Good Energy (ELVN)
1347 Capital Corp (TFSC)
Ameren Illinois Co (AILNP)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
1st Financial Services Corp (FFIS)
1st United Bancorp (FUBC)
2-Track Global (TTG)
ENTERGY ARKANSAS, LLC (EAI)
21st Century Oncology Holdings (RTSX)
24Holdings (TWFH)
Supernova Partners Acquisition Co III, Ltd. (STRE-WT)
30DC (TDCH)
Ameri Metro, Inc. (formerly Yellowwood) (ARMT)
Gores Technology Partners, Inc. (GTPAW)
Bioquest Corp (BQST)
BriaCell Therapeutics Corp. (BCTXW)
3D Total Solutions (DTLS)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2011-08-312011-11-302012-02-292012-05-312012-08-312012-11-302013-02-282013-05-312013-08-312013-11-302014-02-282014-05-312014-08-312014-11-302015-02-282015-05-312015-08-312015-11-302016-02-292016-05-312016-08-312016-11-302017-02-282017-05-312017-08-312017-11-302018-02-282018-05-312018-08-312018-11-302019-02-282019-05-31
Cash25352221221613121029702925211215192122623261723171421211720191218
Accounts Receivable201229195188208258220206231280213217217289222210227289218205223290230208238302273256314339280263
Inventory258252246260319306281288307290289298352319293299348339302319317301289312326286252256285301302335
PP&E8587163168170169176189206205201202210210208209212218224230234238241246249251239243251254254257
Assets1,2831,3011,4361,4331,5091,5341,4741,4611,5181,5591,5331,4881,7411,7641,6541,6871,7471,7821,8701,8421,8561,8891,8131,7751,7981,7751,6211,6031,6951,7251,6501,703
Accounts Payable10597707310686728710993768511510199113143123104111131135112136136109129126151146144139
Long-Term Debt178178178178175175175187204211193191116116433439479475624587549565486454444426290300301340321321
Liabilities557537639606657644547516547549504708939905749755836815940885864909792750761790607579619692653667
Stockholders' Equity7267647978278528909279449711,0101,0297808028599059329119689309569929801,0211,0241,0379841,0141,0241,0761,0339971,036
Income Statement ($MM)2011-08-312011-11-302012-02-292012-05-312012-08-312012-11-302013-02-282013-05-312013-08-312013-11-302014-02-282014-05-312014-08-312014-11-302015-02-282015-05-312015-08-312015-11-302016-02-292016-05-312016-08-312016-11-302017-02-282017-05-312017-08-312017-11-302018-02-282018-05-312018-08-312018-11-302019-02-282019-05-31
Revenue277339294300287375326305319381313312320436378345369446386348368444377360378453391355394431385376
Cost of Revenue165206171179170226194184196233187192186254213202221263224196205250211203211251230208238249227223
Gross Profit112133123121117148132120123148126120134181165143148183162152163194166156168202161147155182158154
R&D
SG&A8291879086101928793981098710911611611411612714312212513112012413013448102104121112106
Tax1-3-45653593326535640521-137112134433
Net Income-306038443741
Cash Flow ($MM)2011-08-312011-11-302012-02-292012-05-312012-08-312012-11-302013-02-282013-05-312013-08-312013-11-302014-02-282014-05-312014-08-312014-11-302015-02-282015-05-312015-08-312015-11-302016-02-292016-05-312016-08-312016-11-302017-02-282017-05-312017-08-312017-11-302018-02-282018-05-312018-08-312018-11-302019-02-282019-05-31
Cash Operating274892146347103463315451153714211134244538942581172989116
Cash Investing15-165-3-2-1-8-17-18-4-2-2-198-1-2-45-3-6-9-214-5-5-6-13-355-4-9-4-4
Cash Financing-32103-72-19-58-315-11-20-42178-48-12211-7-13101-30-36-58-77-35-47-172-283-94-5